Industry reports
Editor highlights

Pharmaceuticals Industry Report Top 500 Pharmaceuticals Industry Report Global

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

PHOENIX Group SWOT Analysis, Strategy, Revenues and Profits

PHOENIX Group SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmacies and Drug Stores | Countries: Europe, Czech Republic, Germany, Sweden, Slovakia (slovak Republic), Italy, Finland, Denmark, Bulgaria, World, Switzerland, Netherlands, Norway, Hungary, Croatia, Bosnia and Herzegovina, Serbia and Montenegro

Worldwide Biotech & Pharmaceutical Co. - Strategic SWOT Analysis Review

Worldwide Biotech & Pharmaceutical Co. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 15 pages

Summary This comprehensive SWOT profile of Worldwide Biotech & Pharmaceutical Co. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities ...

Industries: Pharmaceutical | Countries: World

Dechra Pharmaceuticals plc (Symbol:DPH) SWOT Analysis, Strategy, Revenues and Profits

Dechra Pharmaceuticals plc (Symbol:DPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • April 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Dechra Pharmaceuticals plc SWOT Analysis report provides you a strategic ...

Industries: Pharmaceutical | Countries: Europe, United Kingdom, World, United States, Netherlands

Brother Enterprises Holding Co., Ltd : Ingredients - Company Profile, SWOT and Financial Report

Brother Enterprises Holding Co., Ltd : Ingredients - Company Profile, SWOT and Financial Report

  • $ 125
  • Company report
  • by Canadean Ltd
  • April 2014
  • 28 pages

Synopsis Canadean's "Brother Enterprises Holding Co., Ltd : Ingredients - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, ...

Industries: Vitamin and Supplement | Countries: China, World

Bioactive Ingredients & Product Market by Ingredient (Probiotics, Proteins, Plant Extracts, Minerals, Vitamins, Fibers, Carotenoids), by Product (Functional Foods, & Beverage, Dietary Supplements, Animal Nutrition, Personal Care) - Global Trends & Forecas

Bioactive Ingredients & Product Market by Ingredient (Probiotics, Proteins, Plant Extracts, Minerals, Vitamins, Fibers, Carotenoids), by Product (Functional Foods, & Beverage, Dietary Supplements, Animal Nutrition, Personal Care) - Global Trends & Forecas

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • April 2014
  • 324 pages

The market for bioactive ingredients is projected to experience a growth rate of 7.2% by 2018 to touch $33.6 billion. This estimation is attributed to the widening bioactive industry, which is a result of increased consumer awareness and health concerns. The Asia-Pacific region is the dominant market ...

Industries: Vitamin and Supplement | Countries: World, North America, Europe

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 181 pages

Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Recurrent Malignant Glioma clinical trial scenario. This report provides elemental information and ...

Industries: Drug Discovery and Development | Countries: World

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 120 pages

Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Refractory Acute Myeloid Leukemia clinical trial scenario. This report provides elemental ...

Industries: Pathology | Countries: World

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 198 pages

Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014" provides data on the Refractory Chronic Lymphocytic Leukemia (CLL) clinical trial ...

Industries: Drug Discovery and Development | Countries: World

Refractory Leukemia Global Clinical Trials Review, H1, 2014

Refractory Leukemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 82 pages

Refractory Leukemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Leukemia Global Clinical Trials Review, H1, 2014" provides data on the Refractory Leukemia clinical trial scenario. This report provides elemental information and data relating to the ...

Industries: Drug Discovery and Development | Countries: World

Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014

Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • by Global Data
  • April 2014
  • 166 pages

Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014" provides data on the Refractory Multiple Myeloma clinical trial scenario. This report provides elemental information ...

Industries: Drug Discovery and Development | Countries: World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.